Browse CATs

Browse CATs  internal medicine  cardiology  acute coronary syndrome

Diagnosis Economics Prognosis Therapy Angioplasty Anticoagulation Bypass surgery Secondary prevention

Angina stent implantation reduced repeat angioplasty. Level of evidence 1b Expiry Date June 2003 Angina angioplasty reduced need for antianginal medication and revascularisation, but increased death and MI. Level of evidence 1b Expiry Date June 2003 Angina angioplasty: Stenting reduced restenosis and prevented MI and death in single-vessel disease. Level of evidence 1b Expiry Date June 2003 Angina and angioplasty stents led to less restenosis, but not fewer further events. Level of evidence 1b Expiry Date June 2003 Angioplasty diabetics were not clearly at increased risk of restenosis. Level of evidence 2b Expiry Date June 2003 Angioplasty stents: aspirin alone may not be as safe as aspirin plus ticlopidine. Level of evidence 1b- Expiry Date July 2003 Angioplasty probucol reduced subsequent deaths, MI or revascularisation. Level of evidence 1b Expiry Date July 2003 Angioplasty further intervention was common. Level of evidence 2a Expiry Date July 2003 Angioplasty and stent insertion fewer complications using aspirin and ticlopidine. Level of evidence 1b Expiry Date June 2003 Angioplasty and stents less restenosis occurred and fewer repeat angioplasties were required. Level of evidence 1b Expiry Date July 2003 Coronary artery disease atherectomy was not clearly better than angioplasty. Level of evidence 1b- Expiry Date March 2003 Coronary heart disease c7E3 Fab monoclonal antibody decreased death, MI or unplanned surgery. Level of evidence 1b Expiry Date March 2003 Coronary heart disease abciximab decreased death, MI and need for urgent revascularisation. Level of evidence 1b Expiry Date March 2003 Coronary heart disease multivessel disease, unstable angina and a complex lesion increased the risk of occlusion. Level of evidence 3b Expiry Date March 2003 Coronary heart disease stent implantation increased procedural success in occlusion. Level of evidence 1b Expiry Date March 2003 Coronary heart disease stent placement decreased restenosis. Level of evidence 1b Expiry Date March 2003 Coronary heart disease stent implantation decreased restenosis and reocclusion in chronic occlusion. Level of evidence 2b Expiry Date March 2003 Coronary heart disease chronic coronary occlusions: stent implantation decreased restenosis. Level of evidence 1b Expiry Date March 2003 Ischaemic heart disease angioplasty: abciximab improved survival. Level of evidence 1b Expiry Date July 2003 Unstable angina revascularisation led to fewer symptoms. Level of evidence 2c Expiry Date June 2003 Unstable angina or non Q-wave MI few benefited from early angioplasty and none from giving tPA. Level of evidence 1b Expiry Date July 2003